REPLIGEN CORP
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Oct 27, 2026 (1 day)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| Oct 7, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Sep 9, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Jul 30, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Jul 29, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Jul 7, 2026 | Benchmark | upgrade | Hold → Buy | — | 54% |
| Jul 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Jun 3, 2026 | HSBC | maintain | Buy → Buy | — | 53% |
| May 6, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| May 6, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 20, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| Apr 17, 2026 | Roth Capital | initiate | — → Buy | — | 53% |
| Apr 14, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Mar 23, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Feb 25, 2026 | UBS | maintain | Buy → Buy | $195 | 54% |
| Feb 25, 2026 | Barclays | maintain | Overweight → Overweight | $175 | 53% |
| Feb 25, 2026 | Wells Fargo | maintain | Overweight → Overweight | $180 | 54% |
| Feb 25, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $170 | 58% |
| Jan 16, 2026 | UBS | maintain | Buy → Buy | $200 | 54% |
| Dec 15, 2025 | Barclays | maintain | Overweight → Overweight | $200 | 53% |
| Dec 15, 2025 | Wells Fargo | maintain | Overweight → Overweight | $190 | 54% |
| Oct 29, 2025 | Canaccord Genuity | maintain | Hold → Hold | $165 | 48% |
| Oct 29, 2025 | Barclays | maintain | Overweight → Overweight | $175 | 53% |
| Oct 7, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $175 | 58% |
| Oct 2, 2025 | Barclays | maintain | Overweight → Overweight | $160 | 53% |
| Oct 1, 2025 | HSBC | initiate | — → Buy | $150 | 53% |
| Sep 22, 2025 | Evercore ISI Group | upgrade | In-Line → Outperform | $155 | 58% |
| Sep 12, 2025 | Jefferies | maintain | Hold → Hold | $135 | 52% |
| Sep 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $180 | 44% |
| Jul 30, 2025 | RBC Capital | maintain | Outperform → Outperform | $204 | 55% |
| Jul 30, 2025 | Wells Fargo | maintain | Overweight → Overweight | $175 | 54% |
| Jul 8, 2025 | Evercore ISI Group | maintain | In-Line → In-Line | $130 | 58% |
| Jun 24, 2025 | Barclays | initiate | — → Overweight | $150 | 53% |
| May 5, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $180 | 44% |
| Apr 30, 2025 | RBC Capital | maintain | Outperform → Outperform | $189 | 55% |
| Apr 29, 2025 | JP Morgan | maintain | Overweight → Overweight | $190 | 54% |
| Apr 16, 2025 | Canaccord Genuity | maintain | Hold → Hold | $150 | 48% |
| Mar 18, 2025 | Evercore ISI Group | initiate | — → In-Line | $155 | 58% |
| Feb 21, 2025 | RBC Capital | maintain | Outperform → Outperform | $205 | 55% |
| Feb 21, 2025 | JP Morgan | maintain | Overweight → Overweight | $200 | 54% |
| Feb 21, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $180 | 44% |
| Feb 21, 2025 | Canaccord Genuity | maintain | Hold → Hold | $170 | 48% |
| Jan 23, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $180 | 44% |
| Jan 22, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $180 | 44% |
| Dec 17, 2024 | Canaccord Genuity | initiate | — → Hold | $165 | 48% |
| Nov 14, 2024 | Wolfe Research | initiate | — → Peer Perform | $0 | 53% |
| Sep 26, 2024 | RBC Capital | reiterate | Outperform → Outperform | $205 | 55% |
| Aug 27, 2024 | Wells Fargo | initiate | — → Overweight | $180 | 54% |
| Aug 5, 2024 | Benchmark | reiterate | — → Hold | $0 | 54% |
No cross-platform signals in the last 90 days